145
Participants
Start Date
October 31, 2009
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
warfarin
Oral warfarin (1mg or 2.5mg) titrated to an INR of 2-3.
placebo
Oral placebo (1mg or 2.5mg)
Weill Medical College of Cornell University, New York
Highland Hospital - University of Rochester Medical Center, Rochester
University of Pennsylvania Health System, Philadelphia
Duke University Medical Center, Durham
Medical University of South Carolina, Charleston
University of Miami Miller School of Medicine, Miami
University of Alabama - Birmingham, Birmingham
Vanderbilt University, Nashville
University of Louisville, Louisville
Cleveland Clinic, Cleveland
University of Michigan, Ann Arbor
Mayo Clinic, Rochester
University of Chicago, Chicago
St. Luke's Hospital, Chesterfield
Tulane University, New Orleans
University of Texas Southwestern Medical Center, Dallas
National Jewish Medical and Research Center, Denver
University of Utah Health Research Center, Salt Lake City
University of California - Los Angeles, Los Angeles
University of California - San Francisco, San Francisco
University of Washington, Seattle
Yale University School of Medicine, New Haven
Lead Sponsor
Collaborators (1)
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Duke Clinical Research Institute
OTHER
Duke University
OTHER